Difference between revisions of "Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740)"
Jump to navigation
Jump to search
(Created claim: Collection or Dataset of Origin (P125): Pubtator Central BioC-JSON formatted article files (Q10043), #quickstatements; #temporary_batch_1592945455790) |
(Changed claim: part of (P21): Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (DOI: 10.1007/s11886-020-01292-3) (Q11196)) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / occurs in | Property / occurs in | ||
| - | + | ||
| Property / part of | Property / part of | ||
| - | + | ||
Latest revision as of 19:25, 24 June 2020
Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3)
|
Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3
|
Statements
0 references
0 references
0 references
